Lee R. Hagey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lee R. Hagey has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Matthew D. Krasowski
Department of Pathology, University of Iowa Hospitals and Clinics , Iowa City, IA
7 shared publications - Alan F. Hofmann
Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, 92093-8200, USA
3 shared publications - Albert Mennone
Yale Liver Center, Yale University School of Medicine, New Haven, CT
3 shared publications - Carol J. Soroka
Department of Internal Medicine, Section of Digestive Diseases and Liver Center, Yale University School of Medicine
3 shared publications - James Lorenzen Boyer
Section of Digestive Diseases and Yale Liver Center, Department of Internal Medicine Yale School of Medicine New Haven Connecticut USA
3 shared publications - Alan F. Hofmann
Department of Medicine, University of California at San Diego, MC 0063, La Jolla, California 92093-0063
2 shared publications
Latest Publications
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1122-S1123
Mo1465 VTL C3A Cell Bile Acid Profile and Processing Capabilities
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1122-S1123
Mo1465 VTL C3A Cell Bile Acid Profile and Processing Capabilities
- Open Access
- 25 June 2015
- Published by Wolters Kluwer Health in Hepatology
- Vol. 62 (4) , 1227-1236
Na+/H+ exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury
The intercellular adhesion molecule 1 (ICAM‐1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil‐mediated liver injury in BDL mice. ICAM‐1 has been shown to interact with cytoskeletal ezrin‐radixin‐moesin (ERM) proteins that also interact with the PDZ protein, Na+/H+ exchanger regulatory factor 1 (NHERF‐1/EBP50). In NHERF‐1−/− mice, ERM proteins are significantly reduced in brush‐border membranes from kidney and small intestine. ERM knockdown reduces ICAM‐1 expression in response to tumor necrosis factor alpha. Here we show that NHERF‐1 assembles ERM proteins, ICAM‐1 and F‐actin into a macromolecule complex that is increased in mouse liver after BDL. Compared to wild‐type (WT) mice, both sham‐operated and BDL NHERF‐1−/− mice have lower levels of activated ERM and ICAM‐1 protein in the liver accompanied by significantly reduced hepatic neutrophil accumulation, serum alanine aminotransferase, and attenuated liver injury after BDL. However, total bile acid concentrations in serum and liver of sham and BDL NHERF‐1−/− mice were not significantly different from WT controls, although hepatic tetrahydroxylated bile acids and Cyp3a11 messenger RNA levels were higher in NHERF‐1−/− BDL mice. Conclusion: NHERF‐1 participates in the inflammatory response that is associated with BDL‐induced liver injury. Deletion of NHERF‐1 in mice leads to disruption of the formation of ICAM‐1/ERM/NHERF‐1 complex and reduction of hepatic ERM proteins and ICAM‐1, molecules that are up‐regulated and are essential for neutrophil‐mediated liver injury in cholestasis. Further study of the role of NHERF‐1 in the inflammatory response in cholestasis and other forms of liver injury should lead to discovery of new therapeutic targets in hepatic inflammatory diseases. (Hepatology 2015;62:1227‐1236)
- 25 June 2015
- Published by Wolters Kluwer Health in Hepatology
- Vol. 62 (4) , 1227-1236
Open AccessNa+/H+ exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury
The intercellular adhesion molecule 1 (ICAM‐1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil‐mediated liver injury in BDL mice. ICAM‐1 has been shown to interact with cytoskeletal ezrin‐radixin‐moesin (ERM) proteins that also interact with the PDZ protein, Na+/H+ exchanger regulatory factor 1 (NHERF‐1/EBP50). In NHERF‐1−/− mice, ERM proteins are significantly reduced in brush‐border membranes from kidney and small intestine. ERM knockdown reduces ICAM‐1 expression in response to tumor necrosis factor alpha. Here we show that NHERF‐1 assembles ERM proteins, ICAM‐1 and F‐actin into a macromolecule complex that is increased in mouse liver after BDL. Compared to wild‐type (WT) mice, both sham‐operated and BDL NHERF‐1−/− mice have lower levels of activated ERM and ICAM‐1 protein in the liver accompanied by significantly reduced hepatic neutrophil accumulation, serum alanine aminotransferase, and attenuated liver injury after BDL. However, total bile acid concentrations in serum and liver of sham and BDL NHERF‐1−/− mice were not significantly different from WT controls, although hepatic tetrahydroxylated bile acids and Cyp3a11 messenger RNA levels were higher in NHERF‐1−/− BDL mice. Conclusion: NHERF‐1 participates in the inflammatory response that is associated with BDL‐induced liver injury. Deletion of NHERF‐1 in mice leads to disruption of the formation of ICAM‐1/ERM/NHERF‐1 complex and reduction of hepatic ERM proteins and ICAM‐1, molecules that are up‐regulated and are essential for neutrophil‐mediated liver injury in cholestasis. Further study of the role of NHERF‐1 in the inflammatory response in cholestasis and other forms of liver injury should lead to discovery of new therapeutic targets in hepatic inflammatory diseases. (Hepatology 2015;62:1227‐1236)
- Open Access
- 4 June 2015
- Published by Wolters Kluwer Health in Hepatology
- Vol. 63 (1) , 185-196
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, fibroinflammatory cholangiopathy. The role of the microbiota in PSC etiopathogenesis may be fundamentally important, yet remains obscure. We tested the hypothesis that germ‐free (GF) mutltidrug resistance 2 knockout (mdr2−/−) mice develop a distinct PSC phenotype, compared to conventionally housed (CV) mdr2−/− mice. Mdr2−/− mice (n = 12) were rederived as GF by embryo transfer, maintained in isolators, and sacrificed at 60 days in parallel with age‐matched CV mdr2−/− mice. Serum biochemistries, gallbladder bile acids, and liver sections were examined. Histological findings were validated morphometrically, biochemically, and by immunofluorescence microscopy (IFM). Cholangiocyte senescence was assessed by p16INK4a in situ hybridization in liver tissue and by senescence‐associated β‐galactosidase staining in a culture‐based model of insult‐induced senescence. Serum biochemistries, including alkaline phosphatase, aspartate aminotransferase, and bilirubin, were significantly higher in GF mdr2−/− (P < 0.01). Primary bile acids were similar, whereas secondary bile acids were absent, in GF mdr2−/− mice. Fibrosis, ductular reaction, and ductopenia were significantly more severe histopathologically in GF mdr2−/− mice (P < 0.01) and were confirmed by hepatic morphometry, hydroxyproline assay, and IFM. Cholangiocyte senescence was significantly increased in GF mdr2−/− mice and abrogated in vitro by ursodeoxycholic acid (UDCA) treatment. Conclusions: GF mdr2−/− mice exhibit exacerbated biochemical and histological features of PSC and increased cholangiocyte senescence, a characteristic and potential mediator of progressive biliary disease. UDCA, a commensal microbial metabolite, abrogates senescence in vitro. These findings demonstrate the importance of the commensal microbiota and its metabolites in protecting against biliary injury and suggest avenues for future studies of biomarkers and therapeutic interventions in PSC. (Hepatology 2016;63:185–196)
- 4 June 2015
- Published by Wolters Kluwer Health in Hepatology
- Vol. 63 (1) , 185-196
Open AccessAbsence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, fibroinflammatory cholangiopathy. The role of the microbiota in PSC etiopathogenesis may be fundamentally important, yet remains obscure. We tested the hypothesis that germ‐free (GF) mutltidrug resistance 2 knockout (mdr2−/−) mice develop a distinct PSC phenotype, compared to conventionally housed (CV) mdr2−/− mice. Mdr2−/− mice (n = 12) were rederived as GF by embryo transfer, maintained in isolators, and sacrificed at 60 days in parallel with age‐matched CV mdr2−/− mice. Serum biochemistries, gallbladder bile acids, and liver sections were examined. Histological findings were validated morphometrically, biochemically, and by immunofluorescence microscopy (IFM). Cholangiocyte senescence was assessed by p16INK4a in situ hybridization in liver tissue and by senescence‐associated β‐galactosidase staining in a culture‐based model of insult‐induced senescence. Serum biochemistries, including alkaline phosphatase, aspartate aminotransferase, and bilirubin, were significantly higher in GF mdr2−/− (P < 0.01). Primary bile acids were similar, whereas secondary bile acids were absent, in GF mdr2−/− mice. Fibrosis, ductular reaction, and ductopenia were significantly more severe histopathologically in GF mdr2−/− mice (P < 0.01) and were confirmed by hepatic morphometry, hydroxyproline assay, and IFM. Cholangiocyte senescence was significantly increased in GF mdr2−/− mice and abrogated in vitro by ursodeoxycholic acid (UDCA) treatment. Conclusions: GF mdr2−/− mice exhibit exacerbated biochemical and histological features of PSC and increased cholangiocyte senescence, a characteristic and potential mediator of progressive biliary disease. UDCA, a commensal microbial metabolite, abrogates senescence in vitro. These findings demonstrate the importance of the commensal microbiota and its metabolites in protecting against biliary injury and suggest avenues for future studies of biomarkers and therapeutic interventions in PSC. (Hepatology 2016;63:185–196)
- Top Cited PapersOpen Access
- 1 August 2014
- Published by Elsevier in Journal of Lipid Research
- Vol. 55 (8) , 1553-1595
Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades
- 1 August 2014
- Published by Elsevier in Journal of Lipid Research
- Vol. 55 (8) , 1553-1595
Top Cited PapersOpen AccessKey discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades
- Open Access
- 1 January 2013
- Published by Elsevier in Advances in Nutrition
- Vol. 4 (1) , 29-35
Microbial Biotransformations of Bile Acids as Detected by Electrospray Mass Spectrometry
Many current experiments investigating the effects of diet, dietary supplements, and pre- and probiotics on the intestinal environments do not take into consideration the potential for using bile salts as markers of environmental change. Intestinal bacteria in vertebrates can metabolize bile acids into a number of different structures, with deamidation, hydroxyl group oxidation, and hydroxyl group elimination. Fecal bile acids are readily available to sample and contain a considerable structural complexity that directly relates to intestinal morphology, bile acid residence time in the intestine, and the species of microbial forms in the intestinal tract. Here we offer a classification scheme that can serve as an initial guide to interpret the different bile acid patterns expressed in vertebrate feces.
- 1 January 2013
- Published by Elsevier in Advances in Nutrition
- Vol. 4 (1) , 29-35
Open AccessMicrobial Biotransformations of Bile Acids as Detected by Electrospray Mass Spectrometry
Many current experiments investigating the effects of diet, dietary supplements, and pre- and probiotics on the intestinal environments do not take into consideration the potential for using bile salts as markers of environmental change. Intestinal bacteria in vertebrates can metabolize bile acids into a number of different structures, with deamidation, hydroxyl group oxidation, and hydroxyl group elimination. Fecal bile acids are readily available to sample and contain a considerable structural complexity that directly relates to intestinal morphology, bile acid residence time in the intestine, and the species of microbial forms in the intestinal tract. Here we offer a classification scheme that can serve as an initial guide to interpret the different bile acid patterns expressed in vertebrate feces.
- Open Access
- 23 November 2012
- Published by Wolters Kluwer Health in Hepatology
- Vol. 57 (6) , 2418-2426
Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion
The sea lamprey ( Petromyzon marinus ) is a genetically programmed animal model for biliary atresia, as it loses its bile ducts and gallbladder during metamorphosis. However, in contrast to patients with biliary atresia or other forms of cholestasis who develop progressive disease, the postmetamorphosis lampreys grow normally to adult size. To understand how the adult lamprey thrives without the ability to secrete bile, we examined bile salt homeostasis in larval and adult lampreys. Adult livers were severely cholestatic, with levels of bile salts >1 mM, but no evidence of necrosis, fibrosis, or inflammation. Interestingly, both larvae and adults had normal plasma levels (˜10 μM) of bile salts. In larvae, petromyzonol sulfate (PZS) was the predominant bile salt, whereas the major bile salts in adult liver were sulfated C27 bile alcohols. Cytotoxicity assays revealed that PZS was highly toxic. Pharmacokinetic studies in free-swimming adults revealed that ˜35% of intravenously injected bromosulfophthalein (BSP) was eliminated over a 72-hour period. Collection of urine and feces demonstrated that both endogenous and exogenous organic anions, including biliverdin, bile salts, and BSP, were predominantly excreted by way of the kidney, with minor amounts also detected in feces. Gene expression analysis detected marked up-regulation of orthologs of known organic anion and bile salt transporters in the kidney, with lesser effects in the intestine and gills in adults compared to larvae. These findings indicate that adult lampreys tolerate cholestasis by altering hepatic bile salt composition, while maintaining normal plasma bile salt levels predominantly through renal excretion of bile products. Therefore, we conclude that strategies to accelerate renal excretion of bile salt and other toxins should be beneficial for patients with cholestasis.
- 23 November 2012
- Published by Wolters Kluwer Health in Hepatology
- Vol. 57 (6) , 2418-2426
Open AccessAdult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion
The sea lamprey ( Petromyzon marinus ) is a genetically programmed animal model for biliary atresia, as it loses its bile ducts and gallbladder during metamorphosis. However, in contrast to patients with biliary atresia or other forms of cholestasis who develop progressive disease, the postmetamorphosis lampreys grow normally to adult size. To understand how the adult lamprey thrives without the ability to secrete bile, we examined bile salt homeostasis in larval and adult lampreys. Adult livers were severely cholestatic, with levels of bile salts >1 mM, but no evidence of necrosis, fibrosis, or inflammation. Interestingly, both larvae and adults had normal plasma levels (˜10 μM) of bile salts. In larvae, petromyzonol sulfate (PZS) was the predominant bile salt, whereas the major bile salts in adult liver were sulfated C27 bile alcohols. Cytotoxicity assays revealed that PZS was highly toxic. Pharmacokinetic studies in free-swimming adults revealed that ˜35% of intravenously injected bromosulfophthalein (BSP) was eliminated over a 72-hour period. Collection of urine and feces demonstrated that both endogenous and exogenous organic anions, including biliverdin, bile salts, and BSP, were predominantly excreted by way of the kidney, with minor amounts also detected in feces. Gene expression analysis detected marked up-regulation of orthologs of known organic anion and bile salt transporters in the kidney, with lesser effects in the intestine and gills in adults compared to larvae. These findings indicate that adult lampreys tolerate cholestasis by altering hepatic bile salt composition, while maintaining normal plasma bile salt levels predominantly through renal excretion of bile products. Therefore, we conclude that strategies to accelerate renal excretion of bile salt and other toxins should be beneficial for patients with cholestasis.
- Open Access
- 1 January 2011
- Published by Springer Nature in BMC Biochemistry
- Vol. 12 (1) , 5
The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species
The farnesoid X receptor (FXR), pregnane X receptor (PXR), and vitamin D receptor (VDR) are three closely related nuclear hormone receptors in the NR1H and 1I subfamilies that share the property of being activated by bile salts. Bile salts vary significantly in structure across vertebrate species, suggesting that receptors binding these molecules may show adaptive evolutionary changes in response. We have previously shown that FXRs from the sea lamprey (Petromyzon marinus) and zebrafish (Danio rerio) are activated by planar bile alcohols found in these two species. In this report, we characterize FXR, PXR, and VDR from the green-spotted pufferfish (Tetraodon nigriviridis), an actinopterygian fish that unlike the zebrafish has a bile salt profile similar to humans. We utilize homology modelling, docking, and pharmacophore studies to understand the structural features of the Tetraodon receptors.
- 1 January 2011
- Published by Springer Nature in BMC Biochemistry
- Vol. 12 (1) , 5
Open AccessThe evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species
The farnesoid X receptor (FXR), pregnane X receptor (PXR), and vitamin D receptor (VDR) are three closely related nuclear hormone receptors in the NR1H and 1I subfamilies that share the property of being activated by bile salts. Bile salts vary significantly in structure across vertebrate species, suggesting that receptors binding these molecules may show adaptive evolutionary changes in response. We have previously shown that FXRs from the sea lamprey (Petromyzon marinus) and zebrafish (Danio rerio) are activated by planar bile alcohols found in these two species. In this report, we characterize FXR, PXR, and VDR from the green-spotted pufferfish (Tetraodon nigriviridis), an actinopterygian fish that unlike the zebrafish has a bile salt profile similar to humans. We utilize homology modelling, docking, and pharmacophore studies to understand the structural features of the Tetraodon receptors.
- 1 March 2010
- Published by University of Chicago Press in Physiological and Biochemical Zoology
- Vol. 83 (2) , 308-321
Diversity of Bile Salts in Fish and Amphibians: Evolution of a Complex Biochemical Pathway
Bile salts are the major end metabolites of cholesterol and are also important in lipid and protein digestion, as well as shaping of the gut microflora. Previous studies had demonstrated v...
- 1 March 2010
- Published by University of Chicago Press in Physiological and Biochemical Zoology
- Vol. 83 (2) , 308-321
Diversity of Bile Salts in Fish and Amphibians: Evolution of a Complex Biochemical Pathway
Bile salts are the major end metabolites of cholesterol and are also important in lipid and protein digestion, as well as shaping of the gut microflora. Previous studies had demonstrated v...